Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Effects on Learning and Anxiety
NCT05283382Phase 1Recruiting
- Sponsor
- University of Connecticut
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial in Social Anxiety Disorder (SAD) comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Electrodermal activity at 20 minutes. Started Oct 2024; status: recruiting.
02
Drugs
Zygel
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05283382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283382.